Detalles de la búsqueda
1.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
J Immunother Cancer
; 11(2)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36725084
2.
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.
Eur J Cancer
; 127: 160-172, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32028209
Resultados
1 -
2
de 2
1
Próxima >
>>